Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.62375 | 73 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.5875 | 72 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.93082 | 75 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.86271 | 73 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.59265 | 72 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.05298 | 77 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.74548 | 74 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.6516 | 73 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.48746 | 71 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.43896 | 71 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.68666 | 73 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.62253 | 72 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.7226 | 73 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.68033 | 73 |